Peter Hinterdorfer
Linz, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 95 publications
Switching Spike Plasticity Shapes ACE2 Engagement Across SARS-CoV-2 Variants.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: May 17, 2026
Optimization of Culture Conditions for Pyrroloquinoline Quinone-Overproducing Mutant Hyphomicrobium denitrificans and Its Skin Bioactive Properties.
Journal: Journal of microbiology and biotechnology
Published: March 23, 2026
Comparative Analysis of Two Measurement Modalities for Ex Vivo Analysis of Corneal Stiffness in Porcine Corneas.
Journal: Bioengineering (Basel, Switzerland)
Published: October 22, 2025
Anti-CD38 VLRB-Fc antibodies from transgenic tobacco exhibit potent anti-myeloma activity in vitro and in vivo.
Journal: International journal of biological macromolecules
Published: July 25, 2025
Vertical DNA Nanostructure Arrays: Facilitating Functionalization on Macro-Scale Surfaces.
Journal: ACS nano
Published: April 09, 2025
Single molecule force spectroscopy for evaluating inhibitors of SARS-CoV-2 variants of concern.
Journal: European biophysics journal : EBJ
Published: April 01, 2025
Plant cross-fertilization for production of dual-specific antibodies targeting both Ebola virus-like particles and HER2 protein in F1 plants.
Journal: Genes & genomics
Published: December 10, 2024
Modification of Fc-fusion protein structures to enhance efficacy of cancer vaccine in plant expression system.
Journal: Plant biotechnology journal
Published: October 29, 2024
Plant-derived recombinant macromolecular PAP-IgG Fc as a novel prostate cancer vaccine candidate eliciting robust immune responses.
Journal: Transgenic research
Published: October 18, 2024
Plant-derived EpCAM-Fc fusion proteins induce in vivo immune response to produce IgGs inhibiting invasion and migration of colorectal cancer cells.
Journal: Plant cell reports
Published: October 14, 2024
Plant-Derived Anti-Human Epidermal Growth Factor Receptor 2 Antibody Suppresses Trastuzumab-Resistant Breast Cancer with Enhanced Nanoscale Binding.
Journal: ACS nano
Published: May 20, 2024
Last Updated: 09/26/2026